Claire Chartier
About Claire Chartier
Claire Chartier is the Medical Director of Cardiovascular Diseases at Bristol-Myers Squibb in New Jersey and a member of Mensa France. She has extensive experience in medical roles across various companies including AstraZeneca, Novartis, Merck, Menarini Group, and GSK.
Current Role at Bristol-Myers Squibb
Claire Chartier is currently serving as the Medical Director for Cardiovascular Diseases at Bristol-Myers Squibb. She operates from New Jersey, United States, where she oversees various medical initiatives and strategies related to cardiovascular care. Her role involves directing clinical trials, guiding medical affairs, and ensuring the effective use of cardiology medicines.
Previous Experience with AstraZeneca
Claire Chartier held the position of MSL Manager for Respiratory Diseases at AstraZeneca from 2015 to 2016 in Cambridge, Cambridgeshire, United Kingdom. During her tenure, she was responsible for managing medical science liaisons, coordinating respiratory disease initiatives, and enhancing collaboration between medical and commercial teams.
Career at Novartis
From 2012 to 2015, Claire Chartier served as a Medical Advisor in Ophthalmology at Novartis in Basel, Basel-City, Switzerland. In this role, she contributed to the development of medical strategies, provided scientific support for ophthalmology projects, and played a key role in clinical trial designs and implementations.
Role at Merck
Claire Chartier has extensive experience at Merck, having worked in two significant roles. From 2010 to 2012, she served as the Associate Director of Medical Affairs in Rheumatology in Kenilworth, New Jersey, United States. Prior to this, she worked as a Field Physician from 2008 to 2010, where she gained valuable field experience and contributed to the company’s medical operations.
Education and Academic Background
Claire Chartier has studied at several prestigious institutions, earning a range of qualifications. She attended Emlyon Business School in 2017 and studied Data Science in 2018. At University Paris VI, she studied from 2006 to 2007, and at Paris-Sud University (Paris XI) from 2005 to 2006. She achieved her Doctorate of Medicine from University Paris XII, where she also completed a Master's degree from 2002 to 2003.